# Neuropure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuropure

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.neuropure.com
- Total disclosed funding: $0.5M
- Latest round: Series A (Mar 5, 2007)
- Investors on record: 1

## About

Neuropure Inc. develops neuro-supportive dietary supplements aimed at enhancing nerve health and alleviating nerve pain symptoms, providing natural alternatives to traditional treatments.Neuropure Inc. specializes in neuro-supportive supplements, primarily focusing on nerve health. The company is headquartered in Menlo Park, US. In March 2007, Neuropure raised USD 0.50 million in Series A financing led by Mohr Davidow Ventures, bringing the total amount raised to USD 0.50 million and its valuation to USD 1.803 mn.NeuroPure is a dietary supplement formulated to support nerve health and relieve symptoms such as tingling and discomfort. It features a blend of five bioavailable extracts—Prickly Pear, Passionflower, Marshmallow Root, Corydalis, and California Poppy—targeting nerve function and overall wellness, marketed mainly through the official website.Neuropure operates a direct-to-consumer sales model, generating revenue through online sales. Pricing for a single bottle is set at USD 69, with discounts for bulk purchases: USD 59 per bottle for a three-bottle supply and USD 49 per bottle for six bottles, all backed by a 60-day money-back guarantee.The company plans to utilize its recent funding from March 2007 to expand its product line and penetrate new markets. Neuropure is designing new supplements targeting broader nerve health issues and aims to launch them by 2024. Additionally, it is targeting expansion into European and Asian markets within the next two years.

## Funding rounds

- Series A, Mar 5, 2007, $0.5M — Mohr Davidow Ventures

## Investors

- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series A